Bone Biologics Corporation announced a private placement deal raising $3 million upfront by issuing common stock and warrants priced at $1.42 each. The company may raise an additional $6 million if all warrants are exercised by July 2026. Proceeds will fund clinical trials, patent maintenance, and general corporate needs. The offering closes around July 9, 2026, subject to conditions and stockholder approval.
Anaqua has renewed its partnership with Sony to enhance the strategic role of intellectual property (IP) in Sony's business growth and innovation. Since 2018, Anaqua has supported Sony in managing its global IP assets, including patents and trademark...
Anaqua has renewed its partnership with Sony to support the company's intellectual property (IP) management and innovation strategy. Since 2018, Anaqua has provided Sony with its IP management platform and services, and the renewed agreement includes...
Anaqua has renewed its partnership with Sony to support the management and strategic use of Sony's intellectual property (IP) assets globally. This renewal reflects Sony's increasing focus on IP intelligence as a core part of its business strategy an...
Anaqua has renewed its partnership with Sony to support the company's intellectual property (IP) management as a core driver of business strategy, innovation, and global growth. Since 2018, Anaqua's IP management platform has helped Sony consolidate ...
Anaqua has renewed its partnership with Sony to support Sony's intellectual property (IP) management and innovation strategy. The renewed agreement includes continued use of Anaqua's AQX® platform and AI-powered solutions to improve workflow efficien...
